IMPORTANT NOTES :
- The information available on this Website is the most recently approved version in your country.
- Where information available on paper leaflet inside the pack might not be the most recently approved version.
Approved for Canada
SAPHNELO LQD 300MG VI 1X2.0ML CA
Product Information for Patients
Product Information for Healthcare Professionals
Relato de Eventos Adversos
-
Product Information for Patients
IMPORTANT NOTES :
- The information available on this Website is the most recently approved version in your country.
- Where information available on paper leaflet inside the pack might not be the most recently approved version.
Resources
Product Information for Healthcare Professionals
Resources
Please use the links below to access additional services for both Patients and HCP's.
Continue Downloading?
The Content in this document is only valid on the date that you download it. We may change the content in future.
Copyrights ©2026 AstraZeneca
Copyrights ©2026 AstraZeneca